Literature DB >> 23860801

Percutaneous management of postoperative bile leaks with an ethylene vinyl alcohol copolymer (Onyx).

W Uller1, R Müller-Wille, M Loss, S Hammer, S Schleder, H Goessmann, P Wiggermann, C Stroszczynski, W A Wohlgemuth.   

Abstract

PURPOSE: The management of postoperative bile leakage is challenging especially if the leak rises from the cut surface of the liver and endoscopic treatment fails. Percutaneous transhepatic treatment of bile leaks with biliary drainage is accepted but often requires long-term placement of the drains and is associated with treatment failures. This series evaluates selective embolization of bile ducts with an ethylene vinyl alcohol copolymer (Onyx) in patients with postoperative bile leaks as an alternative treatment option.
MATERIALS AND METHODS: Between January and September 2012, five consecutive patients with persistent postoperative bile leaks underwent percutaneous transhepatic Onyx application and were analyzed regarding procedural management, complications and success rates.
RESULTS: The persistent bile leaks were situated at the cystic stump (after cholecystectomy, n = 2), at the cut surface of the liver (after extended liver resection, n = 2) and at the surface of the liver after surgical exploration and perihepatic abscess (n = 1). Bile drainage alone (endoscopic or percutaneous) failed in all patients and open redo-surgery was deemed potentially harmful. Bilomas were externally drained in all patients before Onyx application. For the closure of bile leaks, Onyx was injected through a microcatheter in a previously built coil nest to keep Onyx in place. All bile leaks were initially closed immediately. In the 2nd week after Onyx embolization, 2 patients showed recurrent small bile leaks without clinical symptoms. In the 4th week after Onyx application, all leaks were closed. No complications occurred.
CONCLUSION: All leaking bile ducts were initially closed immediately after Onyx application. In the 2nd week after Onyx application, 2 patients showed small bile leaks without clinical symptoms. All leaks were closed in the 4th week after Onyx application. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23860801     DOI: 10.1055/s-0033-1350153

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  6 in total

1.  Selective Trans-Catheter Coil Embolization of Cystic Duct Stump in Post-Cholecystectomy Bile Leak.

Authors:  Nariman Nezami; Haddy Jarmakani; Melih Arici; Igor Latich; Hamid Mojibian; Rajasekhara R Ayyagari; Jeffrey S Pollak; Juan Carlos L Perez Lozada
Journal:  Dig Dis Sci       Date:  2019-05-24       Impact factor: 3.199

Review 2.  [Biliary fistulas and biliary congestion after hepatopancreaticobiliary surgery].

Authors:  M-H Dahlke; M Loss; H J Schlitt
Journal:  Chirurg       Date:  2015-06       Impact factor: 0.955

3.  Non-Surgical Management of Bile Leakage After Hepatectomy: A Single-Center Study.

Authors:  Takayoshi Kimura; Tsuyoshi Kawai; Yasufumi Ohuchi; Shinsaku Yata; Akira Adachi; Youhei Takeda; Kazuo Yashima; Soichiro Honjo; Naruo Tokuyasu; Toshihide Ogawa
Journal:  Yonago Acta Med       Date:  2018-12-27       Impact factor: 1.641

4.  How to prevent the postoperative pancreatic fistula with an ethylene vinyl alcohol copolymer (Onyx®): A proposal of a new technique.

Authors:  Francesco Crafa; Francesco Esposito; Adele Noviello; Nicola Moles; Enrico Coppola Bottazzi; Carmelo Lombardi; Antonio Miro; Giulio Lombardi
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-08-31

Review 5.  Progress and Current Limitations of Materials for Artificial Bile Duct Engineering.

Authors:  Qiqi Sun; Zefeng Shen; Xiao Liang; Yingxu He; Deling Kong; Adam C Midgley; Kai Wang
Journal:  Materials (Basel)       Date:  2021-12-06       Impact factor: 3.623

6.  Microwave Ablation for Resolution of Persistent Biloma Following Hepatectomy and Cholecystectomy: Case Report.

Authors:  Alan Yang; Matthew Mitchell; John Di Capua; Avik Som; Junjian Huang; Ralph Weissleder; Sanjeeva Kalva; Raul Uppot
Journal:  Cardiovasc Intervent Radiol       Date:  2021-11-05       Impact factor: 2.740

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.